Selected research
Market Analysis & Forecast
Global Oral Vaccination Market Analysis and Forecast 2026-2032
Market perspective
The global Oral Vaccination market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Oral Vaccination is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Oral Vaccination is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Oral Vaccination is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Oral Vaccination is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Oral Vaccination include Lanzhou Institute, Tiantan Biological, Sanofi, Merck, Shanghai United Cell, GSK, Valneva, Vabiotech and Serum Institute, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Oral Vaccination, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Oral Vaccination, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Vaccination, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Vaccination sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Vaccination market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oral Vaccination sales, projected growth trends, production technology, application and end-user industry.
Oral Vaccination Segment by Company
Lanzhou Institute
Tiantan Biological
Sanofi
Merck
Shanghai United Cell
GSK
Valneva
Vabiotech
Serum Institute
Panacea Biotec Ltd
Halfkin Bio-Pharmaceuticals
EuBiologics
Emergent BioSolutions
Bio-Med
Bibcol
Oral Vaccination Segment by Type
Rotavirus Vaccine
Oral Polio Vaccine
Cholera Vaccine
Other
Oral Vaccination Segment by Application
Public
Private
Oral Vaccination Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccination market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccination and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccination.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Oral Vaccination in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Oral Vaccination manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Vaccination sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rotavirus Vaccine
- Oral Polio Vaccine
- Cholera Vaccine
- Other
Applications
- Public
- Private
Companies covered
- Lanzhou Institute
- Tiantan Biological
- Sanofi
- Merck
- Shanghai United Cell
- GSK
- Valneva
- Vabiotech
- Serum Institute
- Panacea Biotec Ltd
- Halfkin Bio-Pharmaceuticals
- EuBiologics
- Emergent BioSolutions
- Bio-Med
- Bibcol
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Oral Vaccination Market by Type
- 1.2.1 Global Oral Vaccination Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Rotavirus Vaccine
- 1.2.3 Oral Polio Vaccine
- 1.2.4 Cholera Vaccine
- 1.2.5 Other
- 1.3 Oral Vaccination Market by Application
- 1.3.1 Global Oral Vaccination Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Public
- 1.3.3 Private
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Oral Vaccination Market Dynamics
- 2.1 Oral Vaccination Industry Trends
- 2.2 Oral Vaccination Industry Drivers
- 2.3 Oral Vaccination Industry Opportunities and Challenges
- 2.4 Oral Vaccination Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Oral Vaccination Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Oral Vaccination Revenue by Region
- 3.2.1 Global Oral Vaccination Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Oral Vaccination Revenue by Region (2021-2026)
- 3.2.3 Global Oral Vaccination Revenue by Region (2027-2032)
- 3.2.4 Global Oral Vaccination Revenue Market Share by Region (2021-2032)
- 3.3 Global Oral Vaccination Sales Estimates and Forecasts 2021-2032
- 3.4 Global Oral Vaccination Sales by Region
- 3.4.1 Global Oral Vaccination Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Oral Vaccination Sales by Region (2021-2026)
- 3.4.3 Global Oral Vaccination Sales by Region (2027-2032)
- 3.4.4 Global Oral Vaccination Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Oral Vaccination Revenue by Manufacturers
- 4.1.1 Global Oral Vaccination Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Oral Vaccination Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Oral Vaccination Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Oral Vaccination Sales by Manufacturers
- 4.2.1 Global Oral Vaccination Sales by Manufacturers (2021-2026)
- 4.2.2 Global Oral Vaccination Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Oral Vaccination Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Oral Vaccination Sales Price by Manufacturers (2021-2026)
- 4.4 Global Oral Vaccination Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Oral Vaccination Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Oral Vaccination Manufacturers, Product Type & Application
- 4.7 Global Oral Vaccination Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Oral Vaccination Market CR5 and HHI
- 4.8.2 2025 Oral Vaccination Tier 1, Tier 2, and Tier 3
5 Oral Vaccination Market by Type
- 5.1 Global Oral Vaccination Revenue by Type
- 5.1.1 Global Oral Vaccination Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Oral Vaccination Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Oral Vaccination Revenue Market Share by Type (2021-2032)
- 5.2 Global Oral Vaccination Sales by Type
- 5.2.1 Global Oral Vaccination Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Oral Vaccination Sales by Type (2021-2032) & (k units)
- 5.2.3 Global Oral Vaccination Sales Market Share by Type (2021-2032)
- 5.3 Global Oral Vaccination Price by Type
6 Oral Vaccination Market by Application
- 6.1 Global Oral Vaccination Revenue by Application
- 6.1.1 Global Oral Vaccination Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Oral Vaccination Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Oral Vaccination Revenue Market Share by Application (2021-2032)
- 6.2 Global Oral Vaccination Sales by Application
- 6.2.1 Global Oral Vaccination Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Oral Vaccination Sales by Application (2021-2032) & (k units)
- 6.2.3 Global Oral Vaccination Sales Market Share by Application (2021-2032)
- 6.3 Global Oral Vaccination Price by Application
7 Company Profiles
- 7.1 Lanzhou Institute
- 7.1.1 Lanzhou Institute Company Information
- 7.1.2 Lanzhou Institute Business Overview
- 7.1.3 Lanzhou Institute Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Lanzhou Institute Oral Vaccination Product Portfolio
- 7.1.5 Lanzhou Institute Recent Developments
- 7.2 Tiantan Biological
- 7.2.1 Tiantan Biological Company Information
- 7.2.2 Tiantan Biological Business Overview
- 7.2.3 Tiantan Biological Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Tiantan Biological Oral Vaccination Product Portfolio
- 7.2.5 Tiantan Biological Recent Developments
- 7.3 Sanofi
- 7.3.1 Sanofi Company Information
- 7.3.2 Sanofi Business Overview
- 7.3.3 Sanofi Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Sanofi Oral Vaccination Product Portfolio
- 7.3.5 Sanofi Recent Developments
- 7.4 Merck
- 7.4.1 Merck Company Information
- 7.4.2 Merck Business Overview
- 7.4.3 Merck Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Merck Oral Vaccination Product Portfolio
- 7.4.5 Merck Recent Developments
- 7.5 Shanghai United Cell
- 7.5.1 Shanghai United Cell Company Information
- 7.5.2 Shanghai United Cell Business Overview
- 7.5.3 Shanghai United Cell Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Shanghai United Cell Oral Vaccination Product Portfolio
- 7.5.5 Shanghai United Cell Recent Developments
- 7.6 GSK
- 7.6.1 GSK Company Information
- 7.6.2 GSK Business Overview
- 7.6.3 GSK Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 GSK Oral Vaccination Product Portfolio
- 7.6.5 GSK Recent Developments
- 7.7 Valneva
- 7.7.1 Valneva Company Information
- 7.7.2 Valneva Business Overview
- 7.7.3 Valneva Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Valneva Oral Vaccination Product Portfolio
- 7.7.5 Valneva Recent Developments
- 7.8 Vabiotech
- 7.8.1 Vabiotech Company Information
- 7.8.2 Vabiotech Business Overview
- 7.8.3 Vabiotech Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Vabiotech Oral Vaccination Product Portfolio
- 7.8.5 Vabiotech Recent Developments
- 7.9 Serum Institute
- 7.9.1 Serum Institute Company Information
- 7.9.2 Serum Institute Business Overview
- 7.9.3 Serum Institute Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Serum Institute Oral Vaccination Product Portfolio
- 7.9.5 Serum Institute Recent Developments
- 7.10 Panacea Biotec Ltd
- 7.10.1 Panacea Biotec Ltd Company Information
- 7.10.2 Panacea Biotec Ltd Business Overview
- 7.10.3 Panacea Biotec Ltd Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Panacea Biotec Ltd Oral Vaccination Product Portfolio
- 7.10.5 Panacea Biotec Ltd Recent Developments
- 7.11 Halfkin Bio-Pharmaceuticals
- 7.11.1 Halfkin Bio-Pharmaceuticals Company Information
- 7.11.2 Halfkin Bio-Pharmaceuticals Business Overview
- 7.11.3 Halfkin Bio-Pharmaceuticals Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Halfkin Bio-Pharmaceuticals Oral Vaccination Product Portfolio
- 7.11.5 Halfkin Bio-Pharmaceuticals Recent Developments
- 7.12 EuBiologics
- 7.12.1 EuBiologics Company Information
- 7.12.2 EuBiologics Business Overview
- 7.12.3 EuBiologics Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 EuBiologics Oral Vaccination Product Portfolio
- 7.12.5 EuBiologics Recent Developments
- 7.13 Emergent BioSolutions
- 7.13.1 Emergent BioSolutions Company Information
- 7.13.2 Emergent BioSolutions Business Overview
- 7.13.3 Emergent BioSolutions Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 Emergent BioSolutions Oral Vaccination Product Portfolio
- 7.13.5 Emergent BioSolutions Recent Developments
- 7.14 Bio-Med
- 7.14.1 Bio-Med Company Information
- 7.14.2 Bio-Med Business Overview
- 7.14.3 Bio-Med Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Bio-Med Oral Vaccination Product Portfolio
- 7.14.5 Bio-Med Recent Developments
- 7.15 Bibcol
- 7.15.1 Bibcol Company Information
- 7.15.2 Bibcol Business Overview
- 7.15.3 Bibcol Oral Vaccination Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Bibcol Oral Vaccination Product Portfolio
- 7.15.5 Bibcol Recent Developments
8 North America
- 8.1 North America Oral Vaccination Market Size by Type
- 8.1.1 North America Oral Vaccination Revenue by Type (2021-2032)
- 8.1.2 North America Oral Vaccination Sales by Type (2021-2032)
- 8.1.3 North America Oral Vaccination Price by Type (2021-2032)
- 8.2 North America Oral Vaccination Market Size by Application
- 8.2.1 North America Oral Vaccination Revenue by Application (2021-2032)
- 8.2.2 North America Oral Vaccination Sales by Application (2021-2032)
- 8.2.3 North America Oral Vaccination Price by Application (2021-2032)
- 8.3 North America Oral Vaccination Market Size by Country
- 8.3.1 North America Oral Vaccination Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Oral Vaccination Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Oral Vaccination Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Oral Vaccination Market Size by Type
- 9.1.1 Europe Oral Vaccination Revenue by Type (2021-2032)
- 9.1.2 Europe Oral Vaccination Sales by Type (2021-2032)
- 9.1.3 Europe Oral Vaccination Price by Type (2021-2032)
- 9.2 Europe Oral Vaccination Market Size by Application
- 9.2.1 Europe Oral Vaccination Revenue by Application (2021-2032)
- 9.2.2 Europe Oral Vaccination Sales by Application (2021-2032)
- 9.2.3 Europe Oral Vaccination Price by Application (2021-2032)
- 9.3 Europe Oral Vaccination Market Size by Country
- 9.3.1 Europe Oral Vaccination Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Oral Vaccination Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Oral Vaccination Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Oral Vaccination Market Size by Type
- 10.1.1 China Oral Vaccination Revenue by Type (2021-2032)
- 10.1.2 China Oral Vaccination Sales by Type (2021-2032)
- 10.1.3 China Oral Vaccination Price by Type (2021-2032)
- 10.2 China Oral Vaccination Market Size by Application
- 10.2.1 China Oral Vaccination Revenue by Application (2021-2032)
- 10.2.2 China Oral Vaccination Sales by Application (2021-2032)
- 10.2.3 China Oral Vaccination Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Oral Vaccination Market Size by Type
- 11.1.1 Asia Oral Vaccination Revenue by Type (2021-2032)
- 11.1.2 Asia Oral Vaccination Sales by Type (2021-2032)
- 11.1.3 Asia Oral Vaccination Price by Type (2021-2032)
- 11.2 Asia Oral Vaccination Market Size by Application
- 11.2.1 Asia Oral Vaccination Revenue by Application (2021-2032)
- 11.2.2 Asia Oral Vaccination Sales by Application (2021-2032)
- 11.2.3 Asia Oral Vaccination Price by Application (2021-2032)
- 11.3 Asia Oral Vaccination Market Size by Country
- 11.3.1 Asia Oral Vaccination Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Oral Vaccination Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Oral Vaccination Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Oral Vaccination Market Size by Type
- 12.1.1 SAMEA Oral Vaccination Revenue by Type (2021-2032)
- 12.1.2 SAMEA Oral Vaccination Sales by Type (2021-2032)
- 12.1.3 SAMEA Oral Vaccination Price by Type (2021-2032)
- 12.2 SAMEA Oral Vaccination Market Size by Application
- 12.2.1 SAMEA Oral Vaccination Revenue by Application (2021-2032)
- 12.2.2 SAMEA Oral Vaccination Sales by Application (2021-2032)
- 12.2.3 SAMEA Oral Vaccination Price by Application (2021-2032)
- 12.3 SAMEA Oral Vaccination Market Size by Country
- 12.3.1 SAMEA Oral Vaccination Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Oral Vaccination Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Oral Vaccination Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Oral Vaccination Value Chain Analysis
- 13.1.1 Oral Vaccination Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Oral Vaccination Production Mode & Process
- 13.2 Oral Vaccination Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Oral Vaccination Distributors
- 13.2.3 Oral Vaccination Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst